The PRESC1SE-MI trial evaluated whether an accelerated diagnostic pathway for suspected myocardial infarction could improve Emergency Department efficiency without compromising safety. Compared with standard care, the accelerated strategy demonstrated similar safety but did not reduce Emergency Department length of stay. 

In this episode, Jeroen J. Bax PhD, MD, FACC and Jasper Boeddinghaus, MD discuss "PRESC1SE-MI: Safety and efficacy of the ESC 0/1-hour Pathway".

Podden och tillhörande omslagsbild på den här sidan tillhör American College of Cardiology. Innehållet i podden är skapat av American College of Cardiology och inte av, eller tillsammans med, Poddtoppen.